VBIV Shares Outstanding History
Below is a table of the VBIV shares outstanding history going back to 5/2/2016:

Date VBIV Shares Outstanding
5/2/20160.02B
5/9/201632.70M
3/13/201740.02M
5/11/201740.06M
7/31/201740.23M
11/9/201763.80M
2/26/201864.08M
4/25/201864.22M
7/25/201864.38M
11/9/201864.38M
2/25/201997.66M
5/1/201997.66M
8/9/201997.76M
6/30/2019719.51M
11/5/2019178.26M
3/4/2020178.26M
5/5/2020231.20M
10/30/2020242.05M
2/26/2021254.00M
5/7/2021254.20M

Also see: VBIV Market Cap History
VBIV YTD Return
VBIV Historical Shares Outstanding:
+67.85% CAGR
VBIV Historical Shares Outstanding: +67.85% CAGR

Mouse over chart for data details
5/2/2016 ...5/7/2021
VBI Vaccines is a biopharmaceutical company. Co. is developing the prevention and treatment of hepatitis B, with trivalent hepatitis B vaccine, Sci-B-Vac, which is approved for use and available in Israel; and with VBI-2601 (BRII-179), an immunotherapeutic candidate in development for a functional cure for chronic hepatitis B. Co.'s enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. Co.'s primary eVLP program candidates include a glioblastoma vaccine immunotherapeutic candidate, VBI-1901, and a prophylactic cytomegalovirus vaccine candidate, VBI-1501. We show 20 historical shares outstanding datapoints in our coverage of VBIV's shares outstanding history.

Understanding the changing numbers of VBIV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VBIV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VBIV by allowing them to research VBIV shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for VBIV:
VBIV SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VBI Vaccines (VBIV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VCEL Shares Outstanding History
VCYT Shares Outstanding History
VICL Shares Outstanding History
VIV Shares Outstanding History
VIVO Shares Outstanding History
VKTX Shares Outstanding History
VLRX Shares Outstanding History
VNDA Shares Outstanding History
VRAY Shares Outstanding History
VRML Shares Outstanding History
More Healthcare companies »

 

VBIV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.